Publications en collaboration avec des chercheurs de Institute of Oncology Ljubljana (11)

2017

  1. Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

    Molecular Diagnosis and Therapy, Vol. 21, Núm. 3, pp. 337-343

2016

  1. Circulating DNA and survival in solid tumors

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 2, pp. 399-406

  2. In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: Role of mitotic kinases

    Oncotarget, Vol. 7, Núm. 16, pp. 22865-22872

  3. Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

    Breast Cancer Research and Treatment, Vol. 156, Núm. 1

2015

  1. Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: Systematic review and meta-analyses

    Oncotarget, Vol. 6, Núm. 37, pp. 39538-39549

2014

  1. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: Systematic review and meta-analysis

    PLoS ONE, Vol. 9, Núm. 4

  2. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

    Cancer and Metastasis Reviews, Vol. 33, Núm. 1, pp. 295-307

  3. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis

    Cancer Treatment Reviews, Vol. 40, Núm. 9, pp. 1048-1055

2013

  1. HER3 overexpression and survival in solid tumors: A meta-analysis

    Journal of the National Cancer Institute, Vol. 105, Núm. 4, pp. 266-273

  2. The evolving landscape of protein kinases in breast cancer: Clinical implications

    Cancer Treatment Reviews, Vol. 39, Núm. 1, pp. 68-76

2011

  1. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs

    Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2543-2549